Provided by Tiger Fintech (Singapore) Pte. Ltd.

Disc Medicine

52.24
-0.9900-1.86%
Post-market: 52.240.00000.00%18:30 EDT
Volume:1.08M
Turnover:56.92M
Market Cap:1.81B
PE:-13.19
High:54.01
Open:52.87
Low:52.06
Close:53.23
Loading ...

Disc Medicine price target raised to $73 from $70 at Scotiabank

TIPRANKS
·
22 Jan

Disc Medicine Shares Fall 6.8% After Co Commences $200 Mln Public Offering

THOMSON REUTERS
·
22 Jan

Disc Medicine Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
22 Jan

BUZZ-Disc Medicine slips on planned stock sale

Reuters
·
22 Jan

Disc Medicine Shares Fall 4% Premarket After Co Commences $200 Mln Public Offering

THOMSON REUTERS
·
22 Jan

Disc Medicine’s Bitopertin: Regulatory Progress and Accelerated Market Prospects Fuel Buy Rating

TIPRANKS
·
22 Jan

Disc Medicine Inc - Commences $200 Million Underwritten Offering

THOMSON REUTERS
·
22 Jan

Disc Medicine Inc - Proceeds to Fund Research and Clinical Development

THOMSON REUTERS
·
22 Jan

Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
22 Jan

Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire
·
22 Jan

Disc Medicine Price Target Maintained With a $118.00/Share by HC Wainwright & Co.

Dow Jones
·
22 Jan

H.C. Wainwright Keeps Their Buy Rating on Disc Medicine (IRON)

TIPRANKS
·
22 Jan

Disc Medicine Reports 'Positive' Feedback From FDA Meeting

MT Newswires Live
·
22 Jan

Disc Medicine’s Promising Path: Buy Rating Backed by Regulatory Milestones and Market Potential

TIPRANKS
·
22 Jan

Disc Medicine Inc : Scotiabank Raises Target Price to $73 From $70

THOMSON REUTERS
·
21 Jan

Wedbush Raises Price Target on Disc Medicine to $90 From $83, Keeps Outperform Rating

MT Newswires Live
·
21 Jan